Shorter Dual Antiplatelet Therapy Reduces Bleeding Risk Without Increasing MACCE in ACS Patients Undergoing PCI: JAMA Dr Riya Dave11 Oct 2024 9:00 AM ISTReducing the duration of dual antiplatelet therapy (DAPT) to 1 month with subsequent monotherapy with a P2Y12 inhibitor was associated with an...
Anemia Predicts Adverse Outcomes in High-Risk PCI Patients with Impella Support, reports study Dr Riya Dave12 Aug 2024 9:45 AM ISTResearchers found that baseline anemia has a significant impact on patient outcomes after Impella-supported high-risk percutaneous coronary...
Stress Hyperglycemia Ratio Independent Predictor of In-Hospital MACCE in Acute STEMI Dr. Mahalakshmi Sivashankaran18 April 2023 11:00 AM ISTChina: A recent study published in BMC Cardiovascular Disorders Journal has revealed that the stress hyperglycemia ratio (SHR) is a significant and...
Timely access to PCI saves lives in ACS with CS regardless of other facilities of treating hospital MD Bureau20 April 2022 9:45 AM ISTCardiogenic shock (CS) occurs in 6% to 10% of patients with acute coronary syndrome (ACS) and remains the most common cause of in-hospital mortality...
FFR-guided PCI No Better Than CABG in Improving QOL: FAME 3 Trial MD Bureau16 April 2022 10:15 AM ISTIn patients with three-vessel coronary artery disease (CAD), large, randomized trials have demonstrated that coronary revascularization improves the...
GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Dr Kartikeya Kohli10 March 2022 10:30 AM ISTChronic kidney disease (CKD) and end-stage kidney disease (ESKD) are contributors to the health burden and are associated with increased mortality and...
